Channing G.

Channing G. has extensive work experience in the field of clinical operations and research. They began their career in 2010 as a Global Clinical Research Manager at Mölnlycke, where they were responsible for managing multi-phase/site studies and overseeing the approval of clinical investigation protocols and related documents. They also handled budgeting and timelines for selected investigations.

In 2017, Channing joined Celtaxsys, Inc. as the Director of Clinical Operations. In this role, they were accountable for the conduct of Phase I, II, and III clinical trials and CMC activities. They led cross-functional teams and managed external service providers.

From 2019 to 2021, Channing worked at PRA Health Sciences as a Senior Study Manager for the Pfizer Covid-19 vaccine. In this position, they played a crucial role in managing the study and ensuring its successful completion.

In 2021, Channing joined Virios Therapeutics as the Senior Director of Clinical Operations. They held this role until 2023, overseeing clinical operations within the company.

Currently, Channing works as a Clinical Operations Leadership Consultant at Taysha Gene Therapies, starting in 2023.

Channing G. pursued a Masters in Clinical Research Organization and Management from Drexel University College of Medicine. This educational journey took place between 2012 and 2014. Prior to this, from 2006 to 2010, Channing G. attended The University of Georgia, where they completed a degree in Biological Sciences. No specific field of study was mentioned for this degree.